Segment, Customer And Geographic Information

9 Months Ended

Sep. 30, 2011

Segment, Customer And Geographic Information

Segment, Customer And Geographic Information

Note 14. Segment, Customer and Geographic Information

At September 30, 2011 and 2010, the Company operated in only one segment, blood safety. The Company's chief executive officer is the chief operating decision maker who evaluates performance based on the net revenues and operating loss of the blood safety segment. The Company considers the sale of all of its INTERCEPT Blood System products to be similar in nature and function, and any revenue earned from services are minimal.

During the three and nine months ended September 30, 2011 and 2010, the Company had the following significant customers, all of which operate in a country outside of the United States, listed as a percentage of product revenue:

	Three Months Ended September 30,						Nine Months Ended September 30,
	2011			2010			2011			2010
Movaco, S.A.		24	%		22	%		26	%		20	%
Etablissement Francais du Sang		20	%		23	%		20	%		22	%
Delrus Inc.		12	%		13	%		*			15	%
Service Francophone du Sang		*			11	%		*			12	%

* Represents an amount less than 10% of product revenue.

During the three months ended September 30, 2011 and 2010, the Company also recognized government grants and cooperative agreements revenue which represented 16% of total revenue and 9% of total revenue, respectively. During the nine months ended September 30, 2011 and 2010, the Company recognized government grants and cooperative agreements revenue which represented 8% of total revenue and 6% of total revenue, respectively.